Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Digalla[1.1]ferrocenophane and Its Coordination Chemistry: Synthesis and Structure of [{Fe(η5-C5H4)2}2{GaMe}2] and of the Adducts [{Fe(η5-C5H4)2}2{GaMe(D)}2] (D = Monodentate Donor) and [{Fe(η5-C5H4)2}2{GaMe}2D] (D = Bidentate Donor)

Autor: Norman Lenze, Peter Jutzi, and Anja Stammler, Beate Neumann, Alexander Althoff, Hans-Georg Stammler

Publikováno v: Organometallics. 22:2766-2774

Gentle warming of 1,1‘-bis(dimethylgallyl)ferrocene (1) leads to the formation of trimethylgallium and the thermolabile compound [{Fe(η5-C5H4)2}2{GaMe}2] (2), a [1.1]ferrocenophane featuring group 13 elements in bridging positions. While NMR data

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c242772511ec42a61dd3d763ee9dae9e
https://doi.org/10.1021/om030115m

A digalla[1.1]ferrocenophane and its coordination chemistry: Synthesis and structure of [{Fe(eta(5)-C5H4)(2)}(2){GaMe}(2)] and of the adducts [{Fe(eta(5)-C5H4)(2)}(2)GaMe(D)}(2)] (D = monodentate donor) and [Fe(eta(5)-C5H4)(2)}(2){GaMe}(2)D] (D = bidentate donor)

Autor: Althoff, A, Jutzi, Peter, Lenze, N, Neumann, B, Stammler, A, Stammler, Hans-Georg

Gentle warming of 1,1'-bis(dimethylgallyl)ferrocene (1) leads to the formation of trimethylgallium and the thermolabile compound [{Fe(eta(5)-C5H4)(2)}(2){GaMe}(2)] (2), a [1.1] ferrocenophane featuring group 13 elements in bridging positions. While N

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2294::f925cca807f85adaac65583096373706
https://pub.uni-bielefeld.de/record/1611170

A Digalla[1.1]ferrocenophane and Its Coordination Chemistry:  Synthesis and Structure of [{Fe(η⁵-C5H4)2}2{GaMe}2] and of the Adducts [{Fe(η⁵-C5H4)2}2{GaMe(D)}2] (D = Monodentate Donor) and [{Fe(η⁵-C5H4)2}2{GaMe}2D] (D = Bidentate Donor)

Autor: Althoff, A., Jutzi, P., Lenze, N., Neumann, B., Stammler, A., Stammler, H.-G.

Publikováno v: Organometallics; June 2003, Vol. 22 Issue: 13 p2766-2774, 9p

Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort.

Autor: Wong K; National Registry of Rare Kidney Diseases, Bristol, UK.; Department of Renal Medicine, University College London, UK., Pitcher D; National Registry of Rare Kidney Diseases, Bristol, UK.; Department of Renal Medicine, University College London, UK., Braddon F; National Registry of Rare Kidney Diseases, Bristol, UK., Downward L; National Registry of Rare Kidney Diseases, Bristol, UK., Steenkamp R; UK Renal Registry, Bristol, UK., Masoud S; National Registry of Rare Kidney Diseases, Bristol, UK.; Department of Renal Medicine, University College London, UK., Annear N; St George's, University of London, UK., Barratt J; University of Leicester, UK., Bingham C; University of Exeter, UK., Coward RJ; University of Bristol, UK., Chrysochou T; University of Manchester, UK., Game D; Guy's and St Thomas' NHS Foundation Trust, UK., Griffin S; Cardiff University, UK., Hall M; University of Nottingham, UK., Johnson S; Great North Children's Hospital, Newcastle Upon Tyne, UK., Kanigicherla D; University of Manchester, UK., Karet Frankl F; University of Cambridge, UK., Kavanagh D; National Renal Complement Therapeutics Centre (NRCTC), Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.; Complement Therapeutics Research Group, Translational and Clinical Research Institute, Newcastle University, UK., Kerecuk L; Birmingham Women's and Children's NHS Foundation Trust, UK., Maher ER; University of Cambridge, UK., Moochhala S; Royal Free London NHS Foundation Trust, UK., Pinney J; University Hospitals Birmingham NHS Foundation Trust, UK., Sayer JA; Translational and Clinical Research Institute, Newcastle University, UK., Simms R; Department of Infection, Academic Unit of Nephrology, Immunity and Cardiovascular Disease, University of Sheffield, UK., Sinha S; University of Manchester, UK.; Northern Care Alliance NHS Foundation Trust, UK., Srivastava S; South Tyneside and Sunderland NHS Foundation Trust, UK., Tam FWK; Department of Immunology and Inflammation Centre for Inflammatory Disease, Imperial College London, UK., Thomas K; Guy's and St Thomas' NHS Foundation Trust, UK., Turner AN; Edinburgh University, UK., Walsh SB; Department of Renal Medicine, University College London, UK., Waters A; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Wilson P; Department of Renal Medicine, University College London, UK., Wong E; National Renal Complement Therapeutics Centre (NRCTC), Newcastle upon Tyne Hospitals NHS Foundation Trust, UK., Sy KTL; Pfizer, Inc, New York, USA., Huang K; Pfizer, Inc, New York, USA., Ye J; Pfizer, Inc, New York, USA., Nitsch D; UK Renal Registry, Bristol, UK.; London School of Hygiene and Tropical Medicine, London, UK., Saleem M; University of Bristol, UK., Bockenhauer D; Department of Renal Medicine, University College London, UK.; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK., Bramham K; National Registry of Rare Kidney Diseases, Bristol, UK.; King's College London and King's Health Partners, London, UK., Gale DP; National Registry of Rare Kidney Diseases, Bristol, UK.; Department of Renal Medicine, University College London, UK.

Publikováno v: Kidney international reports [Kidney Int Rep] 2024 May 09; Vol. 9 (7), pp. 2067-2083. Date of Electronic Publication: 2024 May 09 (Print Publication: 2024).